This transcript has been edited for clarity.
Robert A. Harrington, MD: Hi. I'm Bob Harrington from Stanford University. I'm here in Barcelona at the European Society of Cardiology (ESC) meeting. First, I have to say, wow, it's fantastic to be back at a live, face-to-face meeting, getting to see friends and colleagues from around the globe in addition to hearing about great science.
While here, I'm having the opportunity to talk with a good friend and colleague, Dr Jonathan Piccini. Jon, welcome.
Jonathan P. Piccini, MD, MHS: Thanks, Bob. It's great to be here.
AFFIRM/EAST-AFNET Generational Divide?
Harrington: Jon is an associate professor of medicine at Duke University, where he's also director of electrophysiology. That's exactly why I have you here, Jon. I want to pick your brain a bit.
As we were talking before we came online here, I'm from the AFFIRM generation in the management of atrial fibrillation (AF). If you get rate control and symptoms are good, then leave them with rate control. You're from more of what I'll call the EAST-AFNET 4 generation, where maybe the first instinct should be to try to get back in sinus rhythm.
Obviously, a large amount of data has been accumulated — clinical data, physiologic data about function of the heart, including the atria; longer-term outcome data — and you're now doing a trial.
Skill Checkup: An 80-Year-Old Man With a History of HFrEF, AF, and T2D Is Experiencing Acute Shortness of Breath
Years of Severe Exhaustion, Fatigue, and Family Stress
Atrial Fibrillation
COMMENTARY
Do Older vs Younger Docs Treat Atrial Fibrillation Differently?
Robert A. Harrington, MD; Jonathan P. Piccini, MD, MHS
DisclosuresSeptember 29, 2022
This transcript has been edited for clarity.
Robert A. Harrington, MD: Hi. I'm Bob Harrington from Stanford University. I'm here in Barcelona at the European Society of Cardiology (ESC) meeting. First, I have to say, wow, it's fantastic to be back at a live, face-to-face meeting, getting to see friends and colleagues from around the globe in addition to hearing about great science.
While here, I'm having the opportunity to talk with a good friend and colleague, Dr Jonathan Piccini. Jon, welcome.
Jonathan P. Piccini, MD, MHS: Thanks, Bob. It's great to be here.
AFFIRM/EAST-AFNET Generational Divide?
Harrington: Jon is an associate professor of medicine at Duke University, where he's also director of electrophysiology. That's exactly why I have you here, Jon. I want to pick your brain a bit.
As we were talking before we came online here, I'm from the AFFIRM generation in the management of atrial fibrillation (AF). If you get rate control and symptoms are good, then leave them with rate control. You're from more of what I'll call the EAST-AFNET 4 generation, where maybe the first instinct should be to try to get back in sinus rhythm.
Obviously, a large amount of data has been accumulated — clinical data, physiologic data about function of the heart, including the atria; longer-term outcome data — and you're now doing a trial.
© 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Robert A. Harrington, Jonathan P. Piccini. Do Older vs Younger Docs Treat Atrial Fibrillation Differently? - Medscape - Sep 29, 2022.
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
Robert A. Harrington, MD
Arthur L. Bloomfield Professor; Chair, Department of Medicine, Stanford University; Chair, Department of Medicine, Stanford Medical Center, Stanford, California
Disclosure: Robert A. Harrington, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Element Science; MyoKardia; WebMD; SignalPath; American Heart Association; Stanford Healthcare; Knowledge2Practice
Received research grant from: Apple; CSL; Sanofi; AstraZeneca; Portola; Janssen; Bristol-Myers Squibb; Novartis
Received income in an amount equal to or greater than $250 from: Element Science; MyoKardia; WebMD; SignalPath; American Heart Association; Stanford Healthcare; Knowledge2Practice
Received grants for clinical research: American College of Cardiology; American Heart Association; National Heart, Lung, and Blood Institute; National Institute on Aging; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Johnson & Johnson; Eli Lilly; Merck; Novartis; Portola; Regado Biosciences; Sanofi; The Medicines Company
Jonathan P. Piccini, MD, MHS
Associate Professor of Medicine, Duke University; Director, Cardiac Electrophysiology, Duke University Health System, Durham, North Carolina
Disclosure: Jonathan P. Piccini, MD, MHS, has disclosed the following relevant financial relationships:
Supported by: grant R01AG074185 from the National Institutes of Health